10. Stakeholder impact statement

Both patients and providers are expected to benefit from these recommendations, as they address concerns regarding patient safety and quality of care, and they take steps to simplify the MBS and make it easier to use and understand. Patient access to services was considered for each recommendation, all of which were intended to reduce inappropriate access without significantly affecting appropriate access.

When considering various recommendations, the Committee considered what impacts they may have on several specific groups, such as paediatric patients, patients from regional and remote areas, and patients from disadvantaged backgrounds. In some instances, recommendations were amended to minimise potential impacts, and specific exceptions may have been granted in rare circumstances, such as for patients with complex congenital heart disease.

Where items have been recommended for deletion, alternative items have been proposed or created when needed. Items that are obsolete have been recommended for deletion without replacement.

The Committee also considered each recommendation’s impact on provider groups to ensure that the changes are reasonable and fair. Where the Committee identified evidence of potential item misuse or safety concerns, recommendations were made to encourage best practice, in line with the overarching purpose of the MBS Review. Reductions in inappropriate use and low-value care are expected to deliver savings for the health system, but a number of cost-neutral changes have also been recommended, including the restructuring of several item groups. The Committee considered the potential financial implications for specific provider groups and took steps (such as the creation of bolt-on items) to ensure that any changes are as fair and reasonable as possible. Some business models, whether using the current items in line with their intended purposes or not, may need to change or adapt to the proposed changes.